Relay well-positioned to generate significant value with RLY-2608, says Stifel
PremiumThe FlyRelay well-positioned to generate significant value with RLY-2608, says Stifel
2M ago
Relay Therapeutics price target raised to $19 from $18 at H.C. Wainwright
Premium
The Fly
Relay Therapeutics price target raised to $19 from $18 at H.C. Wainwright
2M ago
Relay Therapeutics 28.6M share Secondary priced at $7.00
Premium
The Fly
Relay Therapeutics 28.6M share Secondary priced at $7.00
2M ago
Relay Therapeutics price target raised to $24 from $20 at BofA
PremiumThe FlyRelay Therapeutics price target raised to $24 from $20 at BofA
2M ago
Relay Therapeutics upgraded to Buy from Hold at Jefferies
Premium
The Fly
Relay Therapeutics upgraded to Buy from Hold at Jefferies
2M ago
Relay Therapeutics downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Relay Therapeutics downgraded to Perform from Outperform at Oppenheimer
2M ago
Relay Therapeutics’ RLY-2608 Shows Promise in Breast Cancer Trials
PremiumCompany AnnouncementsRelay Therapeutics’ RLY-2608 Shows Promise in Breast Cancer Trials
2M ago
Relay Therapeutics PI3K data exceeds expectations, says Barclays
Premium
The Fly
Relay Therapeutics PI3K data exceeds expectations, says Barclays
2M ago
Relay Therapeutics announces anticipated RLY-2608 next steps
Premium
The Fly
Relay Therapeutics announces anticipated RLY-2608 next steps
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100